Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 113, Issue 1, 2004, Pages 31-35

  Anteby, Eyal Y ^a   Musalam, Banan ^a   Milwidsky, Ariel ^a   Blumenfeld, Anat ^a   Gilis, Shmuel ^a   Valsky, Dan ^a   Hamani, Yaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Intrauterine growth restriction; Placental abruption; Preeclampsia; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FAMILIAL DISEASE; FEMALE; FETUS; FETUS DISEASE; GENE MUTATION; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SOLUTIO PLACENTAE; THROMBOPHILIA;

EID: 1442286426     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.05.002     Document Type: Article

References (26)

1. Khong T.Y., Pearce J.M., Robertson W.B. Acute atherosis in preeclampsia: maternal determinant and fetal outcome in the presence of the lesion. Am. J. Obstet. Gynecol. 157:1987;360-363.
2. Roberts J.M., Taylor R.N., Muscu T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204.
3. Lockwood C.J. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet. Gynecol. 99:2002;333-341.
4. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A.et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Eng. J. Med. 340:1999;9-13.
5. De Vries J.I.P., Dekker G.A., Huijgens P.C., Jacobs C., Blomberg B.M.E., van Gijn H.P. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies. Br. J. Obstet. Gynecol. 104:1997;248-254.
6. van-Pampus M.G., Dekker G.A., Wolf H., Huijgens P.C., Koopman M.M., von Blomberg B.M.et al. High prevalence of hemostatic abnormalities in women with history of severe preeclampsia. Am. J. Obstet Gynecol. 180:1999;1146-1150.
7. Martinelli P, Grandone E, Collaizzo D, Paladini D, Scianname N, Marga, Ninno G. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001;86:428-31.
8. Livingston J.C., Barton J.R., Park V., Haddad B., Phillips O., Sibai B.M. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am. J. Obstet Gynecol. 185:2001;153-157.
9. Alfirevic Z., Mousa H.M., Martlew V., Briscoe L., Perez-Casal M., Toh C.H. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet. Gynecol. 97:2001;753-759.
10. Verspyck E., Le Cam-Duchez V., Goffinet F., Tron F., Marpeau L., Borg Y. Thrombophilia and immunologic disorders in pregnancies as risk factors for small for gestational age infants. Br. J. Obstet. Gynecol. 109:2002;28-33.
11. Salafia C.M., Minior V.K., Pezzulo J.C., Popek E.J., Rosenkrants T.S., Vintzileus A.M. Intrauterine growth restriction in infants of less than thirty two weeks' gestation: associated placental pathologic features. Am. J. Obstet. Gynecol. 173:1995;1049-1057.
12. Salafia C.M., Pezzulo J.C., Lopez Zeno J.A., Simmens S., Minior V.K., Vintzileus A.M. Placental pathologic features in severe preeclampsia. Am. J. Obstet. Gynecol. 173:1995;1097-1105.
13. Redline R.W., Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avscular villi. Hum. Pathol. 26:1995;80-85.
14. Bertina R.M., Koelman B.P.C., Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
15. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703.
16. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G.et al. A candidate genetic risk factor for vascular disease: a common mutation in the methyltetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
17. Leiberman J.R., Fraser D., Weitzman S., Glezerman M. Birthweight curves in southern Israel populations. Israel J. Med. Sci. 29:1993;198-203.
18. Walsh P.S., Metzger D.A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Bio. Tech. 10:1991;506-513.
19. Stampfer M.J., Malinow M.R. Can lowering homocysteine levels reduce cardiovascular risk. N. Eng. J. Med. 322:1995;328-330.
20. Dizon-Townson D.S., Meline L., Nelson L.M., Varner M., Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am. J. Obstet. Gynecol. 177:1997;402-405.
21. Kirkinen P., Salonvaara M., Nikolajev K., Vanninen R., Heinonen K. Antapartum findings in fetal protein C deficiency. Prnat. Diagn. 20:2000;746-749.
22. Johnson S.M., Meyers R.L. Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia. J. Pediatr. Surg. 36:2001;1146-1149.
23. Currie L., Peek M., McNiven M., Prosser I., Mansour J., Ridgway J. Is there an increased maternal-infant prevalence of factor V leiden in association with severe preclampsia. Br. J. Obstet. Gynecol. 109:2002;191-196.
24. Infante-Rivard C., Rivard G.E., Yotov W., Genin E., Guiguet M., Weinberg C.et al. Absence of association of thrombophilia with intrauterine growth restriction. N. Eng. J. Med. 347:2002;19-25.
25. Epslin M.S., Fausett B.M., Fraser A., Kerber R., Mineau G., Carrillo J. et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 344:2001;867-872.
26. Kupferminc M.J., Fait G., Many A., Gordon D., Eldor A., Lessing J.B. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet. Gynecol. 96:2000;45-49.